Breaking News

Hikma Acquires Teligent Sterile Injectable Assets for $45.75M

Marks Hikma's expansion into Canada and includes a portfolio of 25 sterile injectable products.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

p.p1 {margin: 0.0px 0.0px 8.0px 0.0px; font: 11.0px ‘Trebuchet MS’} p.p2 {margin: 0.0px 0.0px 8.0px 0.0px; font: 11.0px ‘Trebuchet MS’; min-height: 12.0px} span.s1 {letter-spacing: 0.0px} Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, has agreed to acquire the Canadian assets of Teligent Inc. for $45.75 million. The transaction is expected to be completed before the end of 1Q22. The acquisition marks Hikma’s expansion into Canad...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters